Central South Dakota News

U.S. Senator Mike Rounds of South Dakota has introduced new legislation aimed at addressing the avian influenza outbreak in the United States. The proposed Avian Influenza Vaccination Strategy Act mandates negotiations between the U.S. Trade Representative and the Secretary of Agriculture to develop a strategy for deploying an avian influenza vaccine.

"Highly Pathogenic Avian Influenza continues to impact millions of birds across the United States, which hurts our producers and our supply chain," stated Senator Rounds. He emphasized the importance of ensuring that trade partners are aligned with the U.S. vaccine strategy, warning that non-acceptance of vaccinated birds could further affect producers.

The bill has received backing from several organizations, including Dakota Provisions, the South Dakota Poultry Industries Association, and the National Turkey Federation. Jordan Woodbury, CEO of Dakota Provisions, highlighted the ongoing threat posed by HPAI to domestic poultry populations and expressed gratitude for Senator Rounds's efforts in addressing trade concerns.

Since February 2022, HPAI has resulted in the loss of 157.7 million birds across all states. In 2024 alone, 18 commercial flocks in South Dakota were affected by HPAI. The virus has also spread to other animals like dairy cattle. Many poultry producers advocate for an HPAI vaccine as a solution; however, its deployment depends on successful negotiations with trade partners who might otherwise block imports of American poultry.

USDA Secretary Brooke Rollins and National Economic Council Director Kevin Hassett are formulating a response strategy focusing on biosecurity and medication against HPAI. The USDA has conditionally approved a vaccine requiring individual injections per bird; full approval will determine deployment specifics based on species.

Senator Rounds has been proactive in advocating for an HPAI vaccine since January 2024 when he urged former USDA Secretary Tom Vilsack and former U.S. Trade Representative Katherine Tai to initiate discussions with trade partners regarding vaccines.